We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.4B
AUM Growth
+$2.35B
Cap. Flow
+$852M
Cap. Flow %
2.9%
Top 10 Hldgs %
20.99%
Holding
3,554
New
245
Increased
1,701
Reduced
1,372
Closed
145
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLSI icon
3301
TriSalus Life Sciences
TLSI
$352M
$72K ﹤0.01%
15,554
ARDX icon
3302
Ardelyx
ARDX
$1.03B
$71K ﹤0.01%
10,295
-45
-0.4% -$266
FUBO icon
3303
FuboTV Inc
FUBO
$293M
$71K ﹤0.01%
4,184
+584
+16% +$10.5K
SUPV
3304
Grupo Supervielle
SUPV
$725M
$71K ﹤0.01%
10,000
TGB
3305
Trekor Metals
TGB
$3.2B
$70K ﹤0.01%
27,957
AQMS icon
3306
Aqua Metals
AQMS
$9.56M
$69K ﹤0.01%
1,854
-8
-0.4% -$418
ANNX icon
3307
Annexon
ANNX
$873M
$67K ﹤0.01%
11,400
+83
+0.7% +$492
AWP
3308
abrdn Global Premier Properties Fund
AWP
$362M
$66K ﹤0.01%
4,726
-225
-5% -$2.85K
CRON
3309
Cronos Group
CRON
$1.17B
$66K ﹤0.01%
30,102
-838
-3% -$1.92K
NRT
3310
North European Oil Royalty Trust
NRT
$83.5M
$66K ﹤0.01%
12,661
-300
-2% -$1.75K
FCO
3311
DELISTED
abrdn Global Income Fund
FCO
$65K ﹤0.01%
10,834
-315,199
-97% -$1.85M
LDI icon
3312
loanDepot
LDI
$298M
$63K ﹤0.01%
22,944
+4,251
+23% +$10K
MIN
3313
Aberdeen Intermediate Income Fund
MIN
$281M
$63K ﹤0.01%
23,112
-100
-0.4% -$272
NG icon
3314
NovaGold Resources
NG
$3.45B
$62K ﹤0.01%
15,145
-338
-2% -$1.44K
CGC
3315
Canopy Growth
CGC
$431M
$61K ﹤0.01%
12,562
+9
+0.1% +$54
OMER icon
3316
Omeros
OMER
$992M
$61K ﹤0.01%
15,443
+1,200
+8% +$5.12K
CSBR icon
3317
Champions Oncology
CSBR
$68.8M
$60K ﹤0.01%
12,252
DDD icon
3318
3D Systems Corp
DDD
$603M
$60K ﹤0.01%
21,059
-496
-2% -$1.43K
TELL
3319
DELISTED
Tellurian Inc.
TELL
$60K ﹤0.01%
61,977
-169,005
-73% -$146K
REKR icon
3320
Rekor Systems
REKR
$94M
$58K ﹤0.01%
48,995
+29,700
+154% +$43.7K
MRDN
3321
Meridian Holdings Inc
MRDN
$178M
$57K ﹤0.01%
2,032
NRO
3322
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$55K ﹤0.01%
13,959
IBRX icon
3323
ImmunityBio
IBRX
$8.2B
$54K ﹤0.01%
14,519
+700
+5% +$3.24K
AMBP icon
3324
Ardagh Metal Packaging
AMBP
$3.02B
$53K ﹤0.01%
+14,125
New +$49.9K
DSX icon
3325
Diana Shipping
DSX
$296M
$53K ﹤0.01%
20,429
+1,059
+5% +$2.72K

Similar funds

Cambridge Investment Research Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Cambridge Investment Research Advisors held 3,554 positions worth $29.4B, up 8.7% from $27.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q3 2024 filing shows 245 new, 1,701 increased, 1,372 reduced and 145 closed positions. Its largest new stake was Return Stacked US Stocks & Managed Futures ETF: 515,268 shares worth $12.6M. The largest sale was State Street Energy Select Sector SPDR ETF, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q3 2024 buy was Return Stacked US Stocks & Managed Futures ETF: 515,268 shares worth $12.6M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q3 2024, an estimated $69M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $28.7M.
  • Cambridge Investment Research Advisors fully exited Goldman Sachs MarketBeta US Equity ETF in Q3 2024, selling an estimated $3.98M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $29.4B portfolio in Q3 2024.
  • Cambridge Investment Research Advisors opened 245 new positions and closed 145 in Q3 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 8.7% quarter-over-quarter to $29.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.